Chris Raymond
Stock Analyst at Raymond James
Total Price Targets
9
Stocks Covered
6
Sectors
Healthcare
Most Recent
Jan 12, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Chris Raymond
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. Common Stock | $47.00 | $5.43 | +765.6% | 1 | Jan 12, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $13.00 | $6.38 | +103.8% | 1 | Jan 6, 2026 |
| SION | Sionna Therapeutics, Inc. | $53.00 | $39.33 | +34.8% | 1 | Jan 5, 2026 |
| MNPR | Monopar Therapeutics Inc. | $123.00 | $53.02 | +132.0% | 1 | Nov 14, 2025 |
| COGT | Cogent Biosciences, Inc. | $60.00 | $36.84 | +62.9% | 2 | Nov 11, 2025 |
| AGIO | Agios Pharmaceuticals, Inc. | $56.00 | $28.15 | +98.9% | 3 | Sep 10, 2024 |
Recent Activity
- Jan 12, 2026— Set$47.00price target onAARD(Aardvark Therapeutics, Inc. Common Stock)
- Jan 6, 2026— Set$13.00price target onTSHA(Taysha Gene Therapies, Inc.)
- Jan 5, 2026— Set$53.00price target onSION(Sionna Therapeutics, Inc.)
- Nov 14, 2025— Set$123.00price target onMNPR(Monopar Therapeutics Inc.)
- Nov 11, 2025— Set$60.00price target onCOGT(Cogent Biosciences, Inc.)
- Sep 10, 2024— Set$56.00price target onAGIO(Agios Pharmaceuticals, Inc.)
- Jun 17, 2024— Set$55.00price target onAGIO(Agios Pharmaceuticals, Inc.)
- May 28, 2024— Set$45.00price target onAGIO(Agios Pharmaceuticals, Inc.)
- Jun 17, 2022— Set$22.00price target onCOGT(Cogent Biosciences, Inc.)
Frequently Asked Questions
Who is Chris Raymond?
Chris Raymond is a stock analyst at Raymond James covering 6 stocks primarily in Healthcare. They have issued 9 price targets since Jun 17, 2022.
What stocks does Chris Raymond cover?
Chris Raymond currently covers 6 stocks, including AGIO, COGT, AARD, TSHA, SION.
What is Chris Raymond's latest price target?
Chris Raymond's most recent price target was $47.00 on AARD (Aardvark Therapeutics, Inc. Common Stock), set on Jan 12, 2026.
What is Chris Raymond's highest price target?
Chris Raymond's highest issued price target is $123.00 on MNPR, set on Nov 14, 2025.
More Analysts at Raymond James
Coverage based on publicly published price targets. Not investment advice.